GlassScriptPhysician profile
Kevin J Ward
NPI 1821092339
$1,113.96
in general payments reported to CMS, 2019-2025
16 companies · $63.52 in 2025
The $63.52 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $50.25 · 2021: $38.55 · 2022: $149 · 2023: $57.32 · 2024: $97.40 · 2025: $63.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $254.00 | 2019-2020 | |
| Boston Scientific Corporation | $238.29 | 2019-2023 | Advantage System |
| Rochester Medical Corporation | $119.49 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $88.97 | 2019-2024 | Bard Urinary Drainage Bag |
| Abbvie INC. | $70.98 | 2019-2024 | |
| Janssen Biotech, INC. | $66.03 | 2019 | |
| Astellas Pharma US INC | $62.62 | 2019 | |
| Ferring Pharmaceuticals INC. | $50.71 | 2019 | |
| Coloplast Corp | $48.83 | 2025 | |
| Dentsply Ih INC. | $34.73 | 2021 | |
| Telix Pharmaceuticals | $20.17 | 2024 | Illuccix |
| Therapeuticsmd, INC. | $18.23 | 2020 | |
| Antares Pharma, INC. | $14.88 | 2019 | |
| Laborie Medical Technologies Corp. | $14.69 | 2025 | |
| Procept Biorobotics Corporation | $7.52 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.